← All indications
Endotoxemia
A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
Drugs by status
Phase 4 trials (11)
Phase 3 trials (2)
Phase 1 trials (9)
Other trials (33)
- metronidazole
- maltodextrin
- agave
- beta-hydroxybutyrate
- bifidobacterium animalis
- chromium ethylenediaminetetraacetic acid
- cocoa bean
- cranberry
- e. coli endotoxin
- ketone
- atazanavir
- ticagrelor
- acetylsalicylic acid
- vancomycin
- ciprofloxacin
- autologous microbiome
- potato
- calcium propionate
- l-epigallocatechin
- maple syrup
- clopidogrel
- soybean
- tea
- sargramostim
- vitamin a
- gts-21
- interferon gamma-1b
- Lactobacillus acidophilus
- whey
- casein
- +3 more
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (24)
- CoMentis
- Atrium Innovations
- Danisco
- GlaxoSmithKline
- LG
- National Heart, Lung, and Blood Institute (NHLBI)
- Green Beat
- Aarhus University
- University of Pennsylvania
- Medical University of Graz
- Ohio State University
- Royal Veterinary and Agricultural University, Denmark
- Seoul National University
- University of Glasgow
- Laval University
- University of Amsterdam
- Arla Foods
- Naturex SA
- DIANA Food
- Alliance for Potato Research and Education
- Government of Quebec
- Nestle
- NutriAgaves
- Fruits d'Or